Parkinson's disease psychosis
Clinical trials for Parkinson's disease psychosis explained in plain language.
Never miss a new study
Get alerted when new Parkinson's disease psychosis trials appear
Sign up with your email to follow new studies for Parkinson's disease psychosis, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Which antipsychotic best tames Parkinson's psychosis? a Head-to-Head trial aims to find out
Disease control Recruiting nowThis trial compares two antipsychotic drugs—pimavanserin and quetiapine—to see which is more effective and safer for treating hallucinations and delusions in people with Parkinson's disease. Up to 60% of Parkinson's patients experience psychosis, which can harm quality of life an…
Matched conditions: PARKINSON'S DISEASE PSYCHOSIS
Phase 4 • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Which antipsychotic works best for lewy body psychosis? new trial aims to find out
Symptom relief Recruiting nowThis study compares two antipsychotic drugs, pimavanserin and quetiapine, to see which one better reduces hallucinations and delusions in people with Parkinson's disease or dementia with Lewy bodies. About 94 participants will be randomly assigned to one of the two medications, a…
Matched conditions: PARKINSON'S DISEASE PSYCHOSIS
Phase 4 • Sponsor: The University of Texas Health Science Center at San Antonio • Aim: Symptom relief
Last updated Jun 26, 2026 14:33 UTC